This report has been commissioned by Asthma Australia, in partnership with the National Asthma Council Australia, as part of broader ongoing consultations to develop the National Asthma Strategy 2016-2020.
In this report, Deloitte Access Economics estimates the total cost of asthma to Australia, including health, productivity and other financial costs (“economic costs”) and “burden of disease” costs (the loss of healthy life).
To provide context to this analysis, the report provides an overview of the epidemiology of asthma, a discussion of prevalence and mortality and, finally, a list of recommendations for future asthma funding and research.
For more information please download the PDF copy of the report.
